We are live on ! Find out more
LCM

Logan Capital Management Portfolio holdings

AUM $2.3B
1-Year Est. Return 30.85%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+30.85%
3 Year Est. Return
+98.58%
5 Year Est. Return
+129.12%
10 Year Est. Return
+521.79%
AUM
$1.41B
AUM Growth
+$27.6M
Cap. Flow
-$27.6M
Cap. Flow %
-1.95%
Top 10 Hldgs %
21.79%
Holding
274
New
9
Increased
93
Reduced
105
Closed
6

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$14M
2
META icon
Meta Platforms (Facebook)
META
+$11.8M
3
TRIP icon
TripAdvisor
TRIP
+$9.73M
4
MIDD icon
Middleby
MIDD
+$8.78M
5
BIIB icon
Biogen
BIIB
+$4.21M

Top Sells

Rank Stock Value
1
DD
Du Pont De Nemours E I
DD
+$14.1M
2
ACN icon
Accenture
ACN
+$11.6M
3
J icon
Jacobs Solutions
J
+$9.55M
4
BKNG icon
Booking.com
BKNG
+$9.5M
5
NTAP icon
NetApp
NTAP
+$9.31M

Sector Composition

Rank Sector Weight
1 Technology 23.87%
2 Industrials 14.56%
3 Consumer Discretionary 14.31%
4 Healthcare 12.13%
5 Communication Services 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTR
251
DELISTED
Frontier Communications Corp.
FTR
$84K 0.01%
961
CIK
252
Credit Suisse Asset Management Income Fund
CIK
$134M
$42K ﹤0.01%
11,600
ISRG icon
253
Intuitive Surgical
ISRG
$127B
-13,500
Closed -$657K
AMJ
254
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
-25,000
Closed -$1.16M
XLNX
255
DELISTED
Xilinx Inc
XLNX
-4,200
Closed -$228K
PNRA
256
DELISTED
Panera Bread Co
PNRA
-1,705
Closed -$301K
AGN
257
DELISTED
Allergan Inc
AGN
-10,564
Closed -$1.31M

Similar funds

Logan Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Logan Capital Management held 274 positions worth $1.41B, up 2% from $1.39B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Logan Capital Management's Q2 2014 filing shows 9 new, 93 increased, 105 reduced and 6 closed positions. Its largest new stake was Biogen: 13,983 shares worth $4.41M. The largest sale was Du Pont De Nemours E I, an estimated $14.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Logan Capital Management's largest Q2 2014 buy was Biogen: 13,983 shares worth $4.41M.
  • Logan Capital Management added most to Procter & Gamble in Q2 2014, an estimated $14M increase.
  • Logan Capital Management's biggest Q2 2014 reduction was Du Pont De Nemours E I, cutting an estimated $14.1M.
  • Logan Capital Management fully exited Allergan Inc in Q2 2014, selling an estimated $1.31M.
  • Logan Capital Management's ten largest holdings make up 22% of its $1.41B portfolio in Q2 2014.
  • Logan Capital Management opened 9 new positions and closed 6 in Q2 2014.
  • Logan Capital Management's portfolio value rose 2% quarter-over-quarter to $1.41B.

Based on Logan Capital Management's 13F filing for Q2 2014, filed 18 Aug 2014.